Report copyright - INTERIM REPORT SECOND QUARTER 2021...Xspray Pharma Interim Report, Q2 2021 12 and for both quarters was SEK -71,861 thousand (-72,106). The Group had SEK 253,737 thousand (137,766)
Please pass captcha verification before submit form